Author:
Nauman C. J.,Morganstern D. E.,Hesketh P. J.
Publisher
Springer Berlin Heidelberg
Reference86 articles.
1. Roscoe JA, Morrow GR, Hickok JT, Stern RM (2000) Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices. J Pain Symptom Manage 20:113–121
2. Hesketh PJ, Plagge P, Bryson JC (1992) Single-dose ondansetron for the prevention of acute cisplatin-in-duced emesis: analysis of efficacy and prognostic factors. In: Bianchi L, Grelot AD, Miller GL (eds) Mechanisms and control of emesis. John Libby Eurotext, Paris, pp 235–236
3. Pollera CF, Giannarelli D (1989) Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model. Cancer 64:1117–1122
4. Martin M, Diaz-Rubio E (1990) Emesis during past pregnancy: a new prognostic factor in chemotherapy-induced emesis. Ann Oncol 1:152–153
5. Morrow GR (1985) The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy. Cancer 55:2766–2770